Loading...
XSHG
603456
Market cap2.30bUSD
Dec 05, Last price  
18.44CNY
1D
1.43%
1Q
-3.71%
Jan 2017
53.92%
IPO
171.58%
Name

Zhejiang Jiuzhou Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHG:603456 chart
P/E
26.86
P/S
3.15
EPS
0.69
Div Yield, %
2.71%
Shrs. gr., 5y
2.26%
Rev. gr., 5y
20.67%
Revenues
5.16b
-6.57%
590,669,767652,528,857833,378,939935,110,2281,143,419,7501,309,584,2041,286,206,7661,444,511,0851,653,177,2101,717,440,5991,862,225,1582,016,815,8532,647,284,1634,063,181,9155,445,105,1545,523,418,1755,160,584,725
Net income
606m
-41.34%
41,423,75267,211,243109,859,779117,049,728136,256,784166,240,814133,278,522200,079,304111,480,460147,605,263157,147,456237,793,378380,584,950633,900,939921,170,3701,033,255,687606,096,350
CFO
992m
-27.10%
82,841,684122,025,843105,299,432111,006,749154,281,690203,861,15310,167,664140,525,669136,646,433244,201,283264,782,500554,161,971400,392,398677,519,2361,225,782,0921,360,323,930991,655,174
Dividend
Jul 04, 20240.5 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Zhejiang Jiuzhou Pharmaceutical Co., Ltd manufactures and sells active pharmaceutical ingredients (API) and intermediates in China and internationally. Its API pipeline comprise central nervous system, non-steroidal, anti-infection, hypoglycemic and antiviral, tumor treatment, anti-depressant, Parkinson, HCV drugs, diabetes, cardiovascular, and respiratory anti-infection drugs. The company also provides asymmetric catalysts and lithium battery materials. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is headquartered in Taizhou, China.
IPO date
Oct 10, 2014
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT